BACKGROUND: Donor dopamine usage is associated with improved immediate graft function after renal transplantation. Although prolonged cold preservation results in an increased vascular permeability, the present study was conducted to examine in vitro and in vivo if dopamine pretreatment influences endothelial barrier function under such conditions. METHODS: To assess cold preservation injury in vitro and in vivo, cultured human umbilical vein endothelial cells (HUVEC) and Lewis donor rats were pretreated with dopamine or isotonic saline prior to cold storage. Injury was determined by lactate dehydrogenase (LDH) release, histology, and functional analysis. RESULTS: In vitro cold storage resulted in intercellular gap formation in both untreated and dopamine pretreated HUVEC. In the latter monolayer integrity was completely restored upon rewarming and paracellular transport of fluorescein isothiocyanate-dextran was significantly reduced. In dopamine treated HUVEC, intercellular gap formation was independent of cell death and was associated with redistribution of junctional proteins and condensation of cytoskeleton proteins. In untreated HUVEC proteolysis and cell death were clearly evident after hypothermia. Closing of intercellular gaps was dependent on p42/p44 activation. Regeneration of adenosine triphosphate was only observed in dopamine pretreated cells. Only in dopamine treated Lewis renal allografts subjected to cold storage, activation of p42/p44 occurred upon rewarming. These grafts had a better renal function and displayed less inflammatory cells five days after transplantation. CONCLUSION: Our study demonstrates beneficial effects of dopamine treatment on cold storage induced endothelial barrier disturbances. This may contribute to the positive effects of catecholamines on immediate graft function of renal allografts in men.
BACKGROUND:Donordopamine usage is associated with improved immediate graft function after renal transplantation. Although prolonged cold preservation results in an increased vascular permeability, the present study was conducted to examine in vitro and in vivo if dopamine pretreatment influences endothelial barrier function under such conditions. METHODS: To assess cold preservation injury in vitro and in vivo, cultured human umbilical vein endothelial cells (HUVEC) and Lewis donorrats were pretreated with dopamine or isotonic saline prior to cold storage. Injury was determined by lactate dehydrogenase (LDH) release, histology, and functional analysis. RESULTS: In vitro cold storage resulted in intercellular gap formation in both untreated and dopamine pretreated HUVEC. In the latter monolayer integrity was completely restored upon rewarming and paracellular transport of fluorescein isothiocyanate-dextran was significantly reduced. In dopamine treated HUVEC, intercellular gap formation was independent of cell death and was associated with redistribution of junctional proteins and condensation of cytoskeleton proteins. In untreated HUVEC proteolysis and cell death were clearly evident after hypothermia. Closing of intercellular gaps was dependent on p42/p44 activation. Regeneration of adenosine triphosphate was only observed in dopamine pretreated cells. Only in dopamine treated Lewis renal allografts subjected to cold storage, activation of p42/p44 occurred upon rewarming. These grafts had a better renal function and displayed less inflammatory cells five days after transplantation. CONCLUSION: Our study demonstrates beneficial effects of dopamine treatment on cold storage induced endothelial barrier disturbances. This may contribute to the positive effects of catecholamines on immediate graft function of renal allografts in men.
Authors: Peter Schnuelle; Wilhelm H Schmitt; Christel Weiss; Antje Habicht; Lutz Renders; Martin Zeier; Felix Drüschler; Katharina Heller; Przemyslaw Pisarski; Bernhard Banas; Bernhard K Krämer; Matthias Jung; Kai Lopau; Christoph J Olbricht; Horst Weihprecht; Peter Schenker; Johan W De Fijter; Benito A Yard; Urs Benck Journal: Clin J Am Soc Nephrol Date: 2017-02-17 Impact factor: 8.237
Authors: H Song; Y Feng; S Hoeger; G Beck; C Hanusch; U Goettmann; H G D Leuvenink; R J Ploeg; J Hillebrands; B A Yard Journal: Clin Exp Immunol Date: 2008-03-12 Impact factor: 4.330
Authors: Ralf M Lösel; Ulf Schnetzke; Paul T Brinkkoetter; Hui Song; Grietje Beck; Peter Schnuelle; Simone Höger; Martin Wehling; Benito A Yard Journal: PLoS One Date: 2010-03-16 Impact factor: 3.240
Authors: C Hanusch; K Nowak; I S Gill; P Törlitz; N Rafat; A M Mueller; K C Van Ackern; B Yard; G C Beck Journal: Clin Exp Immunol Date: 2007-05-22 Impact factor: 4.330
Authors: Patrick Paulus; Pia Ockelmann; Sabine Tacke; Nora Karnowski; Peter Ellinghaus; Bertram Scheller; Johannes Holfeld; Anja Urbschat; Kai Zacharowski Journal: PLoS One Date: 2012-06-20 Impact factor: 3.240
Authors: Charalambos Tsagogiorgas; Johannes Wedel; Maximilia Hottenrott; Michael O Schneider; Uta Binzen; Wolfgang Greffrath; Rolf-Detlef Treede; Bastian Theisinger; Sonja Theisinger; Rüdiger Waldherr; Bernhard K Krämer; Manfred Thiel; Peter Schnuelle; Benito A Yard; Simone Hoeger Journal: PLoS One Date: 2012-08-20 Impact factor: 3.240